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Background: Pulmonary arterial hypertension (PAH) can lead to substantial morphometric remodeling of the pulmonary arteries. Previous studies 
have established coupling relationships between right ventricular (RV) function and pulmonary arterial hemodynamics. Our objective is to develop 
and validate a computational fluid dynamics (CFD) model to estimate spatially averaged wall shear stress (WSS) for patients with PAH, and explore 
correlations between WSS and known clinical metrics. We present a preliminary analysis of the first 6 patients to which the model was fully applied.
methods: Computed tomography angiography (CTA) and right heart catheterization were used to retrospectively acquire images and hemodynamic 
data for 49 PAH patients. Each patient’s pulmonary vascular tree was reconstructed from CT images up to 6 generations. The inlets and outlets 
were extended to 10 times their hydraulic diameters and a volumetric mesh created within element dimensions determined by a systematic mesh 
convergence study. Each patient model is simulated using a structured tree outflow boundary condition that uniquely corresponds to the pulmonary 
vascular resistance of that patient. Constant flow rate simulations were performed using the numerical solver Fluent (ANSYS Inc., Lebanon, NH) after 
adjusting for patient-specific scaling parameters. Finally, spatially averaged WSS on the surface of the pulmonary arterial endothelium were obtained 
during post-processing
results: Computational simulations reveal an elevated spatial average WSS for patients with PAH: 15.4±3.8 dyne/cm2 (Mean±SD), with a strong 
correlation (R2 = 0.86) between WSS and calculated PVR. Preliminary qualitative assessment does not show a definitive relationship between WSS 
and RV dysfunction.
conclusions: Pulmonary arterial WSS obtained by CFD can be used as a physiologically relevant quantitative metric of PAH severity and 
progression. With established understanding of the impact of the underlying pathophysiology on WSS in the pulmonary vasculature, our CFD model 
shows promise as a reliable noninvasive tool to assess disease progression and response to PAH specific therapies.
